Influencing Scientific Decision-Making in Drug Discovery & Development via Integrated Analytical Sciences and Strategies

Overview:
Make plans to attend the 10th annual symposium on Chemical and Pharmaceutical Structure Analysis (CPSA 2007)! This unique event is highly interactive. The program features updated perspectives and experiences on chemical and pharmaceutical structure analysis. Imagination and stimulating discussion are central to each CPSA function and session.

This year’s annual meeting will focus on the current and emerging analytical approaches that appear to be a requisite for decision-making. Specific workflows within the discovery to development continuum will be critically examined. Open discussion will feature real-world experiences with the latest analytical technology and industry initiatives.

The CPSA symposia and roundtables are highly interactive events where opinion leaders share their experiences and visions on chemical and pharmaceutical structure analysis in a collegial setting. The symposia feature comprehensive perspectives on industry-related issues and needs. First-hand experiences with specific applications and technologies are openly discussed. The vendor sessions and poster sessions provide unique opportunities to promote interest and develop sustainable relations.

Goals
This annual event is specifically geared to the needs of researchers attempting to keep pace with faster development times and marketing managers attempting to benchmark emerging trends. A goal of this meeting will be to delineate the importance and urgency of enabling analytical sciences at the frontier of research and development.

CPSA is User Friendly!
CPSA attracts sponsors, thought leaders, and participants who are dedicated to the spirit of cooperation to achieve common goals. Imagination needed.

Program Chair
Nalini Sadagopan, Pfizer

Plenary Lecture
Jonathan L. Josephs, Bristol-Myers Squibb

Keynote Lectures
Brad Ackermann, Eli Lilly and Company
Liang Li, University of Alberta

Poster Session Chairs
Jim Stephenson, RTI International
Eric Yang, GlaxoSmithKline

Vendor Session Chair
Mark Hayward, Lundbeck Research USA

Preliminary list of discussion leaders and invited speakers:

• Brad Ackermann, Eli Lilly and Company
• Leigh Anderson, The Plasma Proteome Institute
• Ray Bakhtiar, Merck Research Laboratories
• Bob Bethem, Intertek-Alta Analytical
• Lucinda Cohen, Pfizer
• Rajesh Desai, Merck Research Laboratories
• Kevin Duffin, Eli Lilly and Company
• Dawn Dufield, Pfizer
• Ayman El-Kattan, Pfizer
• Roger Hayes, Schering-Plough Research Institute
• Mark Hayward, Lundbeck Research USA
• Keith James, Pfizer
• Jonathan Josephs, Bristol-Myers Squibb
• Rick King, Merck
• Jean Lee, Amgen
• Liang Li, University of Alberta
• Bernd Meibohm, University of Tennessee
• Sesha Neervanan, Allergan
• Jeremy Nicholson, Imperial College London
• István Pelczer, Princeton University
• Robyn Rourick, Kalypsys, Inc.
• Nalini Sadagopan, Pfizer
• Petia Shipkova, Bristol-Myers Squibb
• Christine Smith, Pfizer
• Jim Stephenson, RTI International
• Gabriella Szekely-Klepser, Pfizer
• Gary Van Berkel, Oak Ridge Labs
• Dietrich Volmer, MRC Collaborative Centre for Human Nutrition Research
• Eric Yang, GlaxoSmithKline
  

Symposia Feature
Industry Issues and Needs - Analysis Strategies - Performance Benchmarks

Roundtables Feature
Commercial Technology - Mainstream Applications - Analysis Trends

CPSA - Where Technology and Solutions Meet